title: Severe intracranial bleeding related to vitamin K antagonist-ropinirole interaction.
authors.forename: Julia
authors.initials: J
authors.lastname: Grossac
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Ruiz
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Bondon-Guitton
authors.forename: Franck-Emmanuel
authors.initials: FE
authors.lastname: Roux
authors.forename: Olivier
authors.initials: O
authors.lastname: Fourcade
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Montastruc
authors.forename: Thomas
authors.initials: T
authors.lastname: Geeraerts
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000978:Antiparkinson Agents; D007211:Indoles; C046649:ropinirole; D014812:Vitamin K